CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 26 filers reported holding CASI PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $8,000 | 0.0% | 10,002 | 0.0% | 0.00% | – |
Q4 2021 | $8,000 | -33.3% | 10,002 | 0.0% | 0.00% | – |
Q3 2021 | $12,000 | -25.0% | 10,002 | 0.0% | 0.00% | – |
Q2 2021 | $16,000 | -33.3% | 10,002 | 0.0% | 0.00% | – |
Q1 2021 | $24,000 | -20.0% | 10,002 | 0.0% | 0.00% | -100.0% |
Q4 2020 | $30,000 | +100.0% | 10,002 | 0.0% | 0.00% | – |
Q3 2020 | $15,000 | -40.0% | 10,002 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $25,000 | +25.0% | 10,002 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $20,000 | -35.5% | 10,002 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $31,000 | -6.1% | 10,002 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $33,000 | +3.1% | 10,002 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $32,000 | +10.3% | 10,002 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $29,000 | -27.5% | 10,002 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $40,000 | -14.9% | 10,002 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $47,000 | -42.7% | 10,002 | 0.0% | 0.00% | -50.0% |
Q2 2018 | $82,000 | +95.2% | 10,002 | 0.0% | 0.00% | +100.0% |
Q1 2018 | $42,000 | +27.3% | 10,002 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $33,000 | +83.3% | 10,002 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $18,000 | +63.6% | 10,002 | 0.0% | 0.00% | – |
Q2 2017 | $11,000 | -21.4% | 10,002 | 0.0% | 0.00% | – |
Q1 2017 | $14,000 | +16.7% | 10,002 | 0.0% | 0.00% | – |
Q4 2016 | $12,000 | +9.1% | 10,002 | 0.0% | 0.00% | – |
Q3 2016 | $11,000 | -8.3% | 10,002 | 0.0% | 0.00% | – |
Q2 2016 | $12,000 | +9.1% | 10,002 | 0.0% | 0.00% | – |
Q1 2016 | $11,000 | +10.0% | 10,002 | 0.0% | 0.00% | – |
Q4 2015 | $10,000 | -9.1% | 10,002 | 0.0% | 0.00% | – |
Q3 2015 | $11,000 | -38.9% | 10,002 | 0.0% | 0.00% | -100.0% |
Q2 2015 | $18,000 | +20.0% | 10,002 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $15,000 | +15.4% | 10,002 | 0.0% | 0.00% | – |
Q4 2014 | $13,000 | -27.8% | 10,002 | 0.0% | 0.00% | -100.0% |
Q3 2014 | $18,000 | 0.0% | 10,002 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $18,000 | – | 10,002 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellington Shields & Co., LLC | 896,137 | $4,185,000 | 2.27% |
Wellington Shields Capital Management, LLC | 888,333 | $4,149,000 | 0.67% |
Manatuck Hill Partners, LLC | 15,090 | $70,000 | 0.03% |
IHT Wealth Management, LLC | 10,725 | $50,000 | 0.01% |
Perceptive Advisors | 43,682 | $204,000 | 0.01% |
ALPS ADVISORS INC | 153,234 | $716,000 | 0.01% |
ROYCE & ASSOCIATES LP | 78,742 | $368,000 | 0.00% |
Tower Research Capital LLC (TRC) | 5,974 | $28,000 | 0.00% |
METROPOLITAN LIFE INSURANCE CO/NY | 18,585 | $86,792 | 0.00% |
MEEDER ASSET MANAGEMENT INC | 5,863 | $28,000 | 0.00% |